Clinical Trial Update: Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

Trial update on using prophylactic gabapentin to prevent taxane-induced arthralgia and myalgia in breast cancer patients receiving adjuvant chemotherapy (Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Invasive Breast Cancer, Chemotherapeutic Toxicity | Phase 2, Phase 3 | Status: UNKNOWN